PMC:7299399 / 19337-20231
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T89 | 199-203 | Body_part | denotes | mRNA | http://purl.org/sig/ont/fma/fma67122 |
T90 | 213-217 | Body_part | denotes | mRNA | http://purl.org/sig/ont/fma/fma67122 |
T91 | 240-245 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T92 | 659-662 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T192 | 36-37 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T193 | 163-164 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T194 | 188-195 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T195 | 250-251 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T196 | 378-380 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T197 | 657-658 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T198 | 716-719 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T199 | 757-768 | http://purl.obolibrary.org/obo/NCBITaxon_10141 | denotes | guinea pigs |
T200 | 782-783 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T201 | 842-845 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T202 | 862-869 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T203 | 873-879 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T128 | 240-245 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T129 | 246-249 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
T130 | 619-621 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T131 | 659-662 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T84 | 0-94 | Sentence | denotes | On March 16, 2020, Moderna, through a partnership with the Vaccine Research Center at the U.S. |
T85 | 95-656 | Sentence | denotes | National Institutes of Health, enrolled the first participants into a Phase I clinical trial testing an mRNA vaccine (mRNA-1273) encapsulated in lipid NPs—a record time of just 63 days following sequence selection (NCT04283461).65 The enrollment of the first cohort of participants (18 to 55-year-old healthy subjects) concluded on April 16, 2020.66 CureVac and BioNTech (in partnership with Pfizer) are currently working on similar vaccines; Pfizer/BioNTech, in particular, have recently started the recruitment in Phase I/II trials (NCT04368728, NCT04380701). |
T86 | 657-894 | Sentence | denotes | A DNA plasmid vaccine by Inovio Pharmaceuticals (INO-4800) has showed promising results in mice and guinea pigs according to a recent article published in Nature Communications(67) and has entered Phase I testing in humans (NCT04336410). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
284 | 611-621 | Gene | denotes | Phase I/II | |
285 | 92-93 | Gene | denotes | S | Gene:43740568 |
286 | 145-157 | Species | denotes | participants | Tax:9606 |
287 | 364-376 | Species | denotes | participants | Tax:9606 |
288 | 748-752 | Species | denotes | mice | Tax:10090 |
289 | 757-768 | Species | denotes | guinea pigs | Tax:10141 |
290 | 873-879 | Species | denotes | humans | Tax:9606 |
291 | 240-245 | Chemical | denotes | lipid | MESH:D008055 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32519842-32433465-158491 | 834-836 | 32433465 | denotes | 67 |